Computational Search for Inhibitors of SOD1 Mutant Infectivity as Potential Therapeutics for ALS Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26104660 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Marco Carnaroli und 2 weiteren Autor:innen. Beteiligte Einrichtung: DIMEAS, Politecnico di Torino, 10129 Turin, Italy. Hauptthemen laut MEDLINE: Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Familial amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by the selective degeneration of motor neurons. Among the main genetic causes of ALS, over 200 mutations have been identified in the Cu/Zn superoxide dismutase (SOD1) protein, a dimeric metalloenzyme essential for converting superoxides from cellular respiration into less toxic products. Point mutations in SOD1 monomers can induce protein misfolding, which spreads to wild-type monomers through a prion-like mechanism, leading to dysfunctions that contribute to the development of the disease. Understanding the structural and functional differences between the wild-type protein and its mutated variants, as well as developing drugs capable of inhibiting the propagation of misfolding, is crucial for identifying new therapeutic strategies. In this work, seven SOD1 mutations (A4V, G41D, G41S, D76V, G85R, G93A, and I104F) were selected, and three-dimensional models of SOD1 dimers composed of one wild-type monomer and one mutated monomer were generated, along with a control dimer consisting solely of wild-type monomers. Molecular dynamics simulations were conducted to investigate conformational differences between the dimers. Additionally, molecular docking was performed using a library of ligands to identify compounds with high affinity for the mutated dimers. The study reveals some differences in the mutated dimers following molecular dynamics simulations and in the docking of the selected ligands with the various dimers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- DIMEAS, Politecnico di Torino, 10129 Turin, Italy.
- Department of Physics, University of Alberta, Edmonton, AB T6G 2E1, Canada.
ORCID-Profile: Marco Agostino Deriu, Jack Adam Tuszynski
Zitieren
APA
Carnaroli, M., Deriu, M. A., & Tuszynski, J. A. (2025). Computational Search for Inhibitors of SOD1 Mutant Infectivity as Potential Therapeutics for ALS Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26104660
Vancouver
Carnaroli M, Deriu MA, Tuszynski JA. Computational Search for Inhibitors of SOD1 Mutant Infectivity as Potential Therapeutics for ALS Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26104660
BibTeX
@article{Carnaroli2025,
author = {Carnaroli, Marco and Deriu, Marco Agostino and Tuszynski, Jack Adam},
title = {Computational Search for Inhibitors of SOD1 Mutant Infectivity as Potential Therapeutics for ALS Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26104660}
}
EUVIMED